Ibrahim et al. reported that GSDME methylation exhibited potential as a prognostic biomarker of colorectal cancer and pan-cancer (Ibrahim et al., 2019a) (Ibrahim et al., 2019b). The gene discussed is GSDME; the disease is cancer.